These studies might involve patients who have undergone more recent medical therapies for coronary artery disease and chronic heart failure.
In a more recent meta-analysis, adjustment for established coronary risk factors, especially HDL cholesterol, substantially attenuated the magnitude of risk associated with high TG levels, leaving an odds ratio of about 1.7 in individuals with TG levels in the top third of the population, compared with those in the bottom third (8).
However, more recent publications suggest the decline in age-standardised coronary heart disease (CHD) mortality rates has continued since 1997 in countries such as the USA, UK and Australia, and has in fact accelerated in recent years [ 2, 3].
Previous trials have suggested clinical benefit with rescue percutaneous coronary intervention (PCI) after failed fibrinolysis, but more recent, larger studies are conflicting.
However, more recent work further supports the mortality crossover, at least with respect to coronary heart disease mortality (Corti et al., 1999).
More recent studies suggested that AVS and MAC are not only associated with coronary atherosclerosis but also with atherosclerosis in other vascular beds (21– 21).
148 Poorer outcome after percutaneous transluminal coronary angioplasty was found in older studies but not in more recent ones, including studies regarding drug-eluting stents.
More recent work has identified NAFLD as a risk factor not only for premature coronary heart disease and cardiovascular events, but also for early subclinical abnormalities in myocardial structure and function.
In a more recent study, Johnston et al. estimated an annual incremental impact of acute coronary syndrome (ACS) on workplace absenteeism and short-term disability of $465 and $999, respectively [ 8].
More recent studies have confirmed increased F-FDG accumulation in rupture prone plaque of the coronary vasculature [ 84].
